ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in A549 cells. by Traci L. Kruer (3342425)

Analysis of tumour vasculature with the addition of more HT groups. by Deepa Sharma (278210)

Dexamethasone (DEX)-induced transient <i>CPK31</i> expression caused a decrease in As(III) tolerance. by Ruijie Ji (3839032)

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

Descriptive statistics of data presented in Tables 2–5. by Héctor Raúl Olivares-Sánchez (13014866)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

Fig 5 - by Arjen Tilstra (6915227)

Effect of exogenous reduced glutathione on hydrogen peroxide-induced cell death in PhS-treated cells. by Takeo Edamatsu (4885138)

Dose-dependent effect of phenyl sulfate on total glutathione level. by Takeo Edamatsu (4885138)

Effect of hydrogen peroxide on cell death in BSO-treated cells. by Takeo Edamatsu (4885138)

Effects of protein-bound uremic solutes on total glutathione level. by Takeo Edamatsu (4885138)

Effect of exogenous reduced glutathione on cellular vulnerability to hydrogen peroxide in PhS-treated cells. by Takeo Edamatsu (4885138)

Effect of hydrogen peroxide on cellular viability in three uremic solutes-treated cells. by Takeo Edamatsu (4885138)

The ability of KLK6 to decrease death of murine splenocytes relates to its ability to delay the apoptotic cascade. by Isobel A. Scarisbrick (354022)

Effect of hydrogen peroxide on cellular viability in BSO-treated cells. by Takeo Edamatsu (4885138)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

Ephrin-A2 and –A6 expression and EphA4 Tyr-602 phosphorylation decrease from nasal to temporal RGCs. by Ana Laura Ortalli (159899)

TA1 results in a decreased <i>in vivo</i> inflammatory response upon allogeneic cells challenge. by Duncheng Wang (838084)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”

Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs by Chris Wallick (10131528)